
Pharmaceutical Labeling Compliance Assistant
Generate FDA-compliant pharmaceutical product labels effortlessly
What You Can Do
You can quickly draft, review, and update pharmaceutical product labels that meet FDA regulations and current guidance documents. The skill ensures consistent formatting of warnings, precautions, dosage instructions, and all required disclosures—saving you hours of manual compliance checking and reducing the risk of regulatory rejection. You'll get detailed markup with specific citations to relevant FDA guidance.
Features
Automatically check labels against current FDA regulations, 21 CFR Part 201, and recent guidance documents. Identifies missing sections, improper formatting, and potential regulatory gaps.
Generate properly structured contraindications, warnings, and precautions with correct hierarchy, font sizing requirements, and regulatory-approved language patterns.
Draft clear, unambiguous dosage instructions, administration routes, and usage scenarios that meet FDA requirements for patient safety and comprehension.
Create complete label templates from scratch based on active pharmaceutical ingredient (API), product type, and indication. Includes all mandatory sections pre-populated.
Highlight all modifications, additions, and deletions with rationale and regulation citations. Creates a complete audit trail for submissions and internal review.
Ensure consistent terminology, units, and references across multiple label versions, package inserts, and related regulatory documents.
Access pre-approved regulatory language for common disclaimers, storage conditions, and risk statements that align with FDA expectations and recent precedent.
Comprehensive checklist verifying your label is ready for FDA submission, including content, formatting, and all required disclosures.
Example Output
Example 1: Compliance Markup on Existing Label
WARNINGS (needs restructuring per 21 CFR 201.57(c)(2))
- ❌ Current text:
"Do not use if you have heart problems or take certain medications."
- ✅ Revised:
"**CONTRAINDICATIONS**: Do not use if you have:
• History of myocardial infarction
• Uncontrolled hypertension (>180/110 mmHg)
• Concurrent use of monoamine oxidase inhibitors (MAOIs)
Also contraindicated in patients hypersensitive to [INN] or any ingredient."
Rationale: FDA guidance (2019) requires specific disease conditions rather than vague language. Font and hierarchy must follow 21 CFR 201.56(a)(2).
Example 2: Label Template for New Topical Cream
PROPRIETARY NAME™ [INN] Cream, [strength]%
NEW DRUG APPLICATION (NDA) #[XXX-XXX]
Rx ONLY / OTC [as applicable]
BRIEF SUMMARY (see Package Insert for Full Prescribing Information)
[INDICATIONS AND USAGE]
[DOSAGE AND ADMINISTRATION]
[WARNINGS AND PRECAUTIONS]
[ADVERSE REACTIONS]
[STORAGE AND HANDLING]
Example 3: Submission Readiness Checklist
- ✅ All 9 required sections present (21 CFR 201.57(a))
- ✅ Highlight box (if applicable) properly formatted per FDA guidance
- ✅ Dosage expressed in metric units
- ✅ Storage conditions listed with temperature ranges
- ✅ No promotional language in prescribing information
- ✅ Pregnancy/lactation category updated (per 2020 FDA rule)
- ⚠️ Black Box Warning status verified for this drug class
What's Included
- Label Template Library: Pre-built templates for oral solids, injectables, topicals, and biologics—customizable for your specific product type and indication.
- FDA Compliance Checklist: Complete verification guide mapping to 21 CFR 201 requirements, including section-by-section validation points and common rejection reasons.
- Regulatory Language Reference: Curated collection of FDA-approved boilerplate language for warnings, storage, handling, and risk statements based on recent precedent.
- Markup & Change Management Guide: Instructions for tracking modifications with regulatory citations, rationale, and version control for submission packages.
- Example Labeling Documents: Real-world examples of compliant labels across multiple drug classes, showing proper structure, tone, and formatting.
Who It's For
- Regulatory Affairs Specialists
- Medical and Scientific Writers
- Quality Assurance & Compliance Managers
- Pharmaceutical Product Managers
- Contract Research Organization (CRO) Project Managers
Best For
- Drafting new product labels from regulatory requirements
- Reviewing existing labels for FDA compliance gaps
- Updating labels to incorporate new safety data or indication changes
- Preparing labels for FDA submission (NDA, BLA, ANDA)
- Training team members on FDA labeling regulations






